36
Participants
Start Date
May 1, 2017
Primary Completion Date
February 28, 2018
Study Completion Date
February 28, 2018
Tranexamic Acid 25 mg/ml for wound surface moistening
Wound surface moistened with 20 ml of tranexamic acid 25 mg/ml (total dose 500 mg) prior to wound closure
Tranexamic Acid 5 mg/ml as bolus in wound cavity
200 ml of tranexamic acid 5 mg/ml (total dose 1 g) as a bolus instilled into the wound cavity after wound closure, which will remain in the cavity until the activation of drains one hour later
Tranexamic Acid Injectable Solution
1 g of tranexamic acid administered intravenously in accordance with prevailing routines directly prior to planned surgical procedure.
St Olavs Hospital, Trondheim
Aleris Helse
OTHER
St. Olavs Hospital
OTHER